Full Text:   <334>

Summary:  <157>

CLC number: 

On-line Access: 2023-06-13

Received: 2022-12-11

Revision Accepted: 2023-02-27

Crosschecked: 2023-07-21

Cited: 0

Clicked: 663

Citations:  Bibtex RefMan EndNote GB/T7714


Huimin HUANG


Baoqing SUN


-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B 2023 Vol.24 No.6 P.463-484


Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective

Author(s):  Mingtao LIU, Jiali LYU, Xianhui ZHENG, Zhiman LIANG, Baoying LEI, Huihuang CHEN, Yiyin MAI, Huimin HUANG, Baoqing SUN

Affiliation(s):  Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510140, China; more

Corresponding email(s):   sunbaoqing@vip.163.com, huimin@gird.cn

Key Words:  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), Diagnosis, Polymerase chain reaction (PCR), Immunoassay, Radiography

Share this article to: More |Next Article >>>

Mingtao LIU, Jiali LYU, Xianhui ZHENG, Zhiman LIANG, Baoying LEI, Huihuang CHEN, Yiyin MAI, Huimin HUANG, Baoqing SUN. Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective[J]. Journal of Zhejiang University Science B, 2023, 24(6): 463-484.

@article{title="Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective",
author="Mingtao LIU, Jiali LYU, Xianhui ZHENG, Zhiman LIANG, Baoying LEI, Huihuang CHEN, Yiyin MAI, Huimin HUANG, Baoqing SUN",
journal="Journal of Zhejiang University Science B",
publisher="Zhejiang University Press & Springer",

%0 Journal Article
%T Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective
%A Mingtao LIU
%A Jiali LYU
%A Xianhui ZHENG
%A Zhiman LIANG
%A Baoying LEI
%A Huihuang CHEN
%A Yiyin MAI
%A Huimin HUANG
%A Baoqing SUN
%J Journal of Zhejiang University SCIENCE B
%V 24
%N 6
%P 463-484
%@ 1673-1581
%D 2023
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2200625

T1 - Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective
A1 - Mingtao LIU
A1 - Jiali LYU
A1 - Xianhui ZHENG
A1 - Zhiman LIANG
A1 - Baoying LEI
A1 - Huihuang CHEN
A1 - Yiyin MAI
A1 - Huimin HUANG
A1 - Baoqing SUN
J0 - Journal of Zhejiang University Science B
VL - 24
IS - 6
SP - 463
EP - 484
%@ 1673-1581
Y1 - 2023
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2200625

coronavirus disease 2019 (COVID-19) has continued to spread globally since late 2019, representing a formidable challenge to the world’s healthcare systems, wreaking havoc, and spreading rapidly through human contact. With fever, fatigue, and a persistent dry cough being the hallmark symptoms, this disease threatened to destabilize the delicate balance of our global community. Rapid and accurate diagnosis of COVID-19 is a prerequisite for understanding the number of confirmed cases in the world or a region, and an important factor in epidemic assessment and the development of control measures. It also plays a crucial role in ensuring that patients receive the appropriate medical treatment, leading to optimal patient care. Reverse transcription-polymerase chain reaction (RT-PCR) technology is currently the most mature method for detecting viral nucleic acids, but it has many drawbacks. Meanwhile, a variety of COVID-19 detection methods, including molecular biological diagnostic, immunodiagnostic, imaging, and artificial intelligence methods have been developed and applied in clinical practice to meet diverse scenarios and needs. These methods can help clinicians diagnose and treat COVID-19 patients. This review describes the variety of such methods used in China, providing an important reference in the field of the clinical diagnosis of COVID-19.


刘铭涛1, 吕佳丽2, 郑贤惠1, 梁芷曼1, 雷宝颖3, 陈惠凰3, 麦译尹3, 黄惠敏2, 孙宝清1
1广州医科大学附属第一医院, 广州呼吸健康研究院, 呼吸疾病国家重点实验室, 国家呼吸疾病临床医学中心, 国家呼吸医学中心, 检验科, 中国广州市, 510140
2广州医科大学附属第一医院, 广州呼吸健康研究院, 呼吸疾病国家重点实验室, 国家呼吸疾病临床医学中心, 国家呼吸医学中心, 中国广州市, 510140
3广州医科大学, 中国广州市, 511495
摘要: 自2019年底以来,新型冠状病毒感染(COVID-19)继续在全球蔓延,对世界卫生保健系统构成严峻挑战,造成严重破坏,并通过人类接触迅速传播。这种疾病的主要症状是发烧、疲劳和持续的干咳,它威胁到我们全球社会健康系统的平衡。快速准确诊断新冠肺炎是掌握全球或地区确诊病例数量的前提,也是疫情评估和制定控制措施的重要因素。同时,这也确保患者获得合理治疗,为患者获得最佳的护理方案发挥着至关重要的作用。逆转录聚合酶链反应(RT-PCR)技术是目前检测病毒核酸最成熟的方法,但它存在很多缺点。与此同时,分子生物学诊断、免疫诊断、影像学、人工智能等多种新型冠状病毒检测方法已经开发并应用于临床,适应不同场景和需求。这些方法可以帮助临床医生诊断和治疗COVID-19患者。本文总结了目前国内常用于新冠肺炎诊断的多种最新检测方法,为新冠肺炎临床诊断提供了重要参考。
关键词: SARS-CoV-2;COVID-19;诊断;聚合酶链式反应(PCR);免疫分析;影像学

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article


[1]AdamsSH, ParkMJ, SchaubJP, et al., 2020. Medical vulnerability of young adults to severe COVID-19 illness—data from the national health interview survey. J Adolesc Health, 67(3):362-368.

[2]AlqahtaniMS, AbbasM, AlqahtaniA, et al., 2021. A novel computational model for detecting the severity of inflammation in confirmed COVID-19 patients using chest X-ray images. Diagnostics (Basel), 11(5):855.

[3]Al-TawfiqJA, 2020. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel Med Infect Dis, 35:101608.

[4]BaiHX, HsiehB, XiongZ, et al., 2020. Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT. Radiology, 296(2):E46-E54.

[5]BaiY, TaoXN, 2021. Comparison of COVID-19 and influenza characteristics. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(2):87-98.

[6]BalA, DestrasG, GaymardA, et al., 2020. Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect, 26(7):960-962.

[7]BernheimA, MeiXY, HuangMQ, et al., 2020. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology, 295(3):685-691.

[8]BeyerlJ, Rubio-AceroR, CastellettiN, et al., 2021. A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay. eBioMedicine, 70:103502.

[9]BourassaL, PerchettiGA, PhungQ, et al., 2021. A SARS-CoV-2 nucleocapsid variant that affects antigen test performance. J Clin Virol, 141:104900.

[10]BrodinP, 2021. Immune determinants of COVID-19 disease presentation and severity. Nat Med, 27(1):28-33.

[11]CaoYL, JianFC, WangJ, et al., 2023. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature, 614(7948):521-529.

[12]ChakrabortyS, ChandranD, MohapatraRK, et al., 2022. Langya virus, a newly identified Henipavirus in China‍‒Zoonotic pathogen causing febrile illness in humans, and its health concerns: current knowledge and counteracting strategies‒Correspondence. Int J Surg, 105:106882.

[13]ChanJF, YuanSF, KokKH, et al., 2020. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 395(10223):514-523.

[14]ChandranD, DhamaK, ChakrabortyS, et al., 2022. Monkeypox: an update on current knowledge and research advances. J Exp Biol Agric Sci, 10(4):679-688.

[15]ChauCH, StropeJD, FiggWD, 2020. COVID-19 clinical diagnostics and testing technology. Pharmacotherapy, 40(8):857-868.

[16]ChenXP, HuWJ, YangM, et al., 2021. Risk factors for the delayed viral clearance in COVID-19 patients. J Clin Hypertens (Greenwich), 23(8):1483-1489.

[17]ChenYJ, ShiY, ChenY, et al., 2020. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: a promising method in the point-of-care detection. Biosens Bioelectron, 169:112642.

[18]ChengZJ, ShanJ, 2020. 2019 Novel coronavirus: where we are and what we know. Infection, 48(2):155-163.

[19]ChengZJ, ZhanZQ, XueMS, et al., 2023. Public health measures and the control of COVID-19 in China. Clin Rev Allergy Immunol, 64(1):1-16.

[20]ConteC, 2021. Possible link between SARS-CoV-2 infection and Parkinson’s disease: the role of Toll-like receptor 4. Int J Mol Sci, 22(13):7135.

[21]CormanVM, LandtO, KaiserM, et al., 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill, 25(3):2000045.

[22]CormanVM, HaageVC, BleickerT, et al., 2021. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe, 2(7):e311-e319.

[23]da SilvaSJR, da SilvaCTA, GuarinesKM, et al., 2020. Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infect Dis, 6(9):2319-2336.

[24]DaiWH, ZhangB, JiangXM, et al., 2020. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science, 368(6497):1331-1335.

[25]DhedaK, RuhwaldM, TheronG, et al., 2013. Point-of-care diagnosis of tuberculosis: past, present and future. Respirology, 18(2):217-232.

[26]DhochakN, SinghalT, KabraSK, et al., 2020. Pathophysiology of COVID-19: why children fare better than adults? Indian J Pediatr, 87(7):537-546.

[27]DouYZ, SuJ, ChenSX, et al., 2022. A smartphone-based three-in-one biosensor for co-detection of SARS-CoV-2 viral RNA, antigen and antibody. Chem Commun, 58(41):6108-6111.

[28]FangYC, ZhangHQ, XieJC, et al., 2020. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology, 296(2):E115-E117.

[29]FangZF, SunBQ, ZhuAR, et al., 2021. Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and common respiratory pathogens in COVID-19 patients. J Med Virol, 93(5):3257-3260.

[30]FitzpatrickMC, PandeyA, WellsCR, et al., 2021. Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests. Lancet, 397(10268):24-25.

[31]FrankMG, NguyenKH, BallJB, et al., 2022. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav Immun, 100:267-277.

[32]GaoJW, WangCH, ChuYJ, et al., 2022. Graphene oxide-graphene Van der Waals heterostructure transistor biosensor for SARS-CoV-2 protein detection. Talanta, 240:123197.

[33]GaoW, TianJJ, HuangKL, et al., 2019. Ultrafast, universal and visual screening of dual genetically modified elements based on dual super PCR and a lateral flow biosensor. Food Chem, 279:246-251.

[34]GaoYP, HuangKJ, WangFT, et al., 2022. Recent advances in biological detection with rolling circle amplification: design strategy, biosensing mechanism, and practical applications. Analyst, 147(15):3396-3414.

[35]García-FiñanaM, BuchanIE, 2021. Rapid antigen testing in COVID-19 responses: SARS-CoV-2 transmission was reduced with measures centered on rapid antigen testing. Science, 372(6542):571-572.

[36]GauglerS, SottasPE, BlumK, et al, 2021. Fully automated dried blood spot sample handling and extraction for serological testing of SARS-CoV-2 antibodies. Drug Test Anal, 13(1):223-226.

[37]GiliA, PaggiR, RussoC, et al., 2021. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening. Int J Infect Dis, 105:391-396.

[38]GillJL, WilliamsJW, JacksonST, et al., 2009. Pleistocene megafaunal collapse, novel plant communities, and enhanced fire regimes in North America. Science, 326(5956):1100-1103.

[39]GreenwoodD, RichardS, BarerM, et al., 2012. Medical Microbiology. Elsevier, Amsterdam, The Netherlands.

[40]GrubaughND, LadnerJT, LemeyP, et al., 2019. Tracking virus outbreaks in the twenty-first century. Nat Microbiol, 4(1):10-19.

[41]GuW, MillerS, ChiuCY, 2019. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol, 14:319-338.

[42]GuoM, TaoWY, FlavellRA, et al., 2021. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol, 18(4):269-283.

[43]HarcourtJ, TaminA, LuXY, et al., 2020. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerg Infect Dis, 26(6):1266-1273.

[44]HirotsuY, MaejimaM, ShibusawaM, et al., 2020. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. Int J Infect Dis, 99:397-402.

[45]HirotsuY, MaejimaM, ShibusawaM, et al., 2021a. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: comparison with RT-qPCR. Int J Infect Dis, 105:7-14.

[46]HirotsuY, SugiuraH, MaejimaM, et al., 2021b. Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19. Int J Infect Dis, 108:263-269.

[47]HollandLA, KaelinEA, MaqsoodR, et al., 2020. An 81-nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (January to March 2020). J Virol, 94(14):e00711-20.

[48]HuXJ, DengQY, LiJM, et al., 2020. Development and clinical application of a rapid and sensitive loop-mediated isothermal amplification test for SARS-CoV-2 infection. mSphere, 5(4):e00808-20.

[49]HuangL, TianSL, ZhaoWH, et al., 2020. Multiplexed detection of biomarkers in lateral-flow immunoassays. Analyst, 145(8):2828-2840.

[50]IscoveNN, BarbaraM, GuM, et al., 2002. Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nat Biotechnol, 20(9):940-943.

[51]IslamA, SangkhamS, TiwariA, et al., 2022a. Association between global monkeypox cases and meteorological factors. Int J Environ Res Public Health, 19(23):15638.

[52]IslamA, HasanMN, AhammedT, et al., 2022b. Association of household fuel with acute respiratory infection (ARI) under-five years children in Bangladesh. Front Public Health, 10:985445.

[53]IslamA, HemoMK, ChopraH, et al., 2022c. Old enemy with a new face: re-emerging monkeypox disease-an update. J Pure Appl Microbiol, 16(S1):2972-2988.

[54]IslamA, HaqueA, RahmanA, et al., 2022d. A review on measures to rejuvenate immune system: natural mode of protection against coronavirus infection. Front Immunol, 13:837290.

[55]IslamA, AhammedT, NoorSTA, 2022e. An estimation of five-decade long monkeypox case fatality rate: systematic review and meta-analysis. J Pure Appl Microbiol, 16(S1):3036-3047.

[56]IslamA, RahmanA, JakariyaM, et al., 2023a. A 30-day follow-up study on the prevalence of SARS-CoV-2 genetic markers in wastewater from the residence of COVID-19 patient and comparison with clinical positivity. Sci Total Environ, 858:159350.

[57]IslamA, AdeizaSS, AminR, et al., 2023b. A bibliometric study on Marburg virus research with prevention and control strategies. Front Trop Dis, 3:1068364.

[58]IslamA, HossenF, RahmanA, et al., 2023c. An opinion on Wastewater-Based Epidemiological Monitoring (WBEM) with Clinical Diagnostic Test (CDT) for detecting high-prevalence areas of community COVID-19 infections. Curr Opin Environ Sci Health, 31:100396.

[59]JakariyaM, AhmedF, IslamA, et al., 2022. Wastewater-based epidemiological surveillance to monitor the prevalence of SARS-CoV-2 in developing countries with onsite sanitation facilities. Environ Pollut, 311:119679.

[60]KamesJ, HolcombDD, KimchiO, et al., 2020. Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design. Sci Rep, 10:15643.

[61]KarpDG, DanhK, EspinozaNF, et al., 2020. A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots. Sci Rep, 10:20188.

[62]KobayashiY, MitsudomiT, 2013. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected? Transl Lung Cancer Res, 2(5):354-363.

[63]KoczulaKM, GallottaA, 2016. Lateral flow assays. Essays Biochem, 60(1):111-120.

[64]KrüttgenA, CornelissenCG, DreherM, et al., 2021. Comparison of the SARS-CoV-2 rapid antigen test to the real star SARS-CoV-2 RT PCR kit. J Virol Methods, 288:114024.

[65]KubinaR, DziedzicA, 2020. Molecular and serological tests for COVID-19. A comparative review of SARS-CoV-2 coronavirus laboratory and point-of-care diagnostics. Diagnostics, 10(6):434.

[66]KucirkaLM, LauerSA, LaeyendeckerO, et al., 2020. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med, 173(4):262-267.

[67]KuntipN, JaprungD, PongprayoonP, 2021. What happens when a complementary DNA meets miR-29a cancer biomarker in complex with a graphene quantum dot. ACS Appl Bio Mater, 4(12):8368-8376.

[68]KurhadeC, ZouJ, XiaHJ, et al., 2023. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat Med, 29(2):344-347.

[69]la MarcaA, CapuzzoM, PagliaT, et al., 2020. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online, 41(3):483-499.

[70]LanciottiRS, CalisherCH, GublerDJ, et al., 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol, 30(3):545-551.

[71]LeixnerG, Voill-GlaningerA, BonnerE, et al., 2021. Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting. Int J Infect Dis, 108:353-356.

[72]LiF, YeQH, ChenMT, et al., 2021. Cas12aFDet: a CRISPR/Cas12a-based fluorescence platform for sensitive and specific detection of Listeria monocytogenes serotype 4c. Anal Chim Acta, 1151:338248.

[73]LiTW, ShaoYF, FuLY, et al., 2018. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med, 96(1):85-96.

[74]LiYY, YangX, ZhaoWA, 2017. Emerging microtechnologies and automated systems for rapid bacterial identification and antibiotic susceptibility testing. SLAS Technol, 22(6):585-608.

[75]LiZT, YiYX, LuoXM, et al., 2020. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol, 92(9):1518-1524.

[76]LiuJ, GratzJ, AmourC, et al., 2016. Optimization of quantitative PCR methods for enteropathogen detection. PLoS ONE, 11(6):e0158199.

[77]LvDF, YingQM, WengYS, et al., 2020. Dynamic change process of target genes by RT-PCR testing of SARS-CoV-2 during the course of a Coronavirus Disease 2019 patient. Clin Chim Acta, 506:172-175.

[78]MackayIM, 2004. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect, 10(3):190-212.

[79]MahalakshmiAM, RayB, TuladharS, et al., 2021. Does COVID-19 contribute to development of neurological disease? Immun Inflamm Dis, 9(1):48-58.

[80]ManentiA, MaggettiM, CasaE, et al., 2020. Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples. J Med Virol, 92(10):2096-2104.

[81]McDadeTW, McNallyEM, ZelikovichAS, et al., 2020. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay. PLoS ONE, 15(8):e0237833.

[82]MenchinelliG, BordiL, LiottiFM, et al., 2021. Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups. Clin Chem Lab Med, 59(8):1468-1476.

[83]MercerTR, SalitM, 2021. Testing at scale during the COVID-19 pandemic. Nat Rev Genet, 22(7):415-426.

[84]MetzkerML, 2010. Sequencing technologies—the next generation. Nat Rev Genet, 11(1):31-46.

[85]MiessePK, CollierBB, GrantRP, 2022. Monitoring of SARS-CoV-2 antibodies using dried blood spot for at-home collection. Sci Rep, 12:5812.

[86]MinaMJ, ParkerR, LarremoreDB, 2020. Rethinking Covid-19 test sensitivity—a strategy for containment. N Engl J Med, 383(22):e120.

[87]MohammadiMR, OmidiAH, SabatiH, 2022. Current trends and new methods of detection of SARS-CoV-2 infection. Cell Mol Biomed Rep, 2(3):138-150.

[88]MontesinosI, GrusonD, KabambaB, et al., 2020. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol, 128:104413.

[89]MorleyGL, TaylorS, JossiS, et al., 2020. Sensitive detection of SARS-CoV-2-specific antibodies in dried blood spot samples. Emerg Infect Dis, 26(12):2970-2973.

[90]MotayoBO, OluwasemowoOO, OlusolaBA, et al., 2021. Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences. Int J Infect Dis, 103:282-287.

[91]MuhiS, TaylerN, HoangT, et al., 2021. Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: a validation and implementation study. Lancet Reg Health West Pac, 9:100115.

[92]NicolT, LefeuvreC, SerriO, et al., 2020. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). J Clin Virol, 129:104511.

[93]NieJH, LiQQ, WuJJ, et al., 2020. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect, 9(1):680-686.

[94]OranDP, TopolEJ, 2020. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med, 173(5):362-367.

[95]Oude MunninkBB, NieuwenhuijseDF, SteinM, et al., 2020. Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands. Nat Med, 26(9):1405-1410.

[96]PanF, YeTH, SunP, et al., 2020. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology, 295(3):715-721.

[97]PangB, XuJY, LiuYM, et al., 2020. Isothermal amplification and ambient visualization in a single tube for the detection of SARS-CoV-2 using loop-mediated amplification and CRISPR technology. Anal Chem, 92(24):16204-16212.

[98]PeelingRW, OlliaroPL, BoerasDI, et al., 2021. Scaling up COVID-19 rapid antigen tests: promises and challenges. Lancet Infect Dis, 21(9):e290-e295.

[99]PetoJ, 2020. Covid-19 mass testing facilities could end the epidemic rapidly. BMJ, 368:m1163.

[100]PumfordEA, LuJK, SpaczaiI, et al., 2020. Developments in integrating nucleic acid isothermal amplification and detection systems for point-of-care diagnostics. Biosens Bioelectron, 170:112674.

[101]QiuF, WangHJ, ZhangZK, et al., 2020. Laboratory testing techniques for SARS-CoV-2. J Southern Med Univ, 40(2):164-167 (in Chinese).

[102]QuailMA, SmithM, CouplandP, et al., 2012. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13:341.

[103]RajpalS, LakhyaniN, SinghAK, et al., 2021. Using handpicked features in conjunction with ResNet-50 for improved detection of COVID-19 from chest X-ray images. Chaos Solitons Fractals, 145:110749.

[104]RutalaWA, WeberDJ, 2017. Guideline for disinfection and sterilization in healthcare facilities, 2008. Centers for Disease Control and Prevention. https://stacks.‍cdc.‍gov/view/cdc/47378

[105]Safiabadi TaliSH, LeBlancJJ, SadiqZ, et al., 2021. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Microbiol Rev, 34(3):e00228-20.

[106]SakibMH, NishatAA, IslamMT, et al., 2021. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2. Comput Biol Med, 136:104759.

[107]SandleT, 2013. Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals: Technology, Validation and Current Regulations. Woodhead Publishing Ltd., Oxford, UK.

[108]SantiagoI, 2020. Trends and innovations in biosensors for COVID-19 mass testing. ChemBioChem, 21(20):2880-2889.

[109]ShenB, ZhengY, ZhangX, et al., 2020. Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-CoV-2 IgM/IgG. Am J Transl Res, 12(4):1348-1354.

[110]ShiP, DongYQ, YanHC, et al., 2020. Impact of temperature on the dynamics of the COVID-19 outbreak in China. Sci Total Environ, 728:138890.

[111]ShiR, ShanC, DuanXM, et al., 2020. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature, 584(7819):120-124.

[112]ShuYL, McCauleyJ, 2017. GISAID: global initiative on sharing all influenza data-from vision to reality. Euro Surveill, 22(13):30494.

[113]SinghJ, SharmaS, NaraS, 2015. Evaluation of gold nanoparticle based lateral flow assays for diagnosis of enterobacteriaceae members in food and water. Food Chem, 170:470-483.

[114]SiroisM, 2014. Laboratory Procedures for Veterinary Technicians, 6th Ed. Elsevier, St. Louis, USA.

[115]SmyrlakiI, EkmanM, LentiniA, et al., 2020. Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR. Nat Commun, 11:4812.

[116]SoniA, HerbertC, FilippaiosA, et al., 2022. Comparison of rapid antigen tests’ performance between Delta and Omicron variants of SARS-CoV-2: secondary analysis from a serial home self-testing study. Ann Intern Med, 175(12):1685-1692.

[117]SotoI, Zamorano-IllanesR, BecerraR, et al., 2023. A new COVID-19 detection method based on CSK/QAM visible light communication and machine learning. Sensors, 23(3):1533.

[118]SteinmanJB, LumFM, HoPPK, et al., 2020. Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics. Proc Natl Acad Sci USA, 117(40):24620-24626.

[119]SunT, GuanJ, 2020. Novel coronavirus and the central nervous system. Eur J Neurol, 27(9):e52.

[120]TaleghaniN, TaghipourF, 2021. Diagnosis of COVID-19 for controlling the pandemic: a review of the state-of-the-art. Biosens Bioelectron, 174:112830.

[121]TanCW, ChiaWN, QinXJ, et al., 2020. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol, 38(9):1073-1078.

[122]TsangNNY, SoHC, NgKY, et al., 2021. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. Lancet Infect Dis, 21(9):1233-1245.

[123]VerkhratskyA, LiQ, MelinoS, et al., 2020. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct, 15:28.

[124]WangCJ, LiY, PanYC, et al., 2022. Clinical and immune response characteristics among vaccinated persons infected with SARS-CoV-2 delta variant: a retrospective study. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(11):899-914.

[125]WangR, QianCY, PangYA, et al., 2021. opvCRISPR: one-pot visual RT-LAMP-CRISPR platform for SARS-CoV-2 detection. Biosens Bioelectron, 172:112766.

[126]WangXN, ZhuYS, JiangHW, et al., 2020. Detection methods of SARS-CoV-2. Chem Life, 40(8):‍1258-1269 (in Chinese).

[127]WangYH, DongCJ, HuY, et al., 2020. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology, 296(2):E55-E64.

[128]WangYW, MaDD, ZhangGP, et al., 2022. An electrochemical immunosensor based on SPA and rGO-PEI-Ag-Nf for the detection of arsanilic acid. Molecules, 27(1):172.

[129]WenJQ, ChengYF, LingRS, et al., 2020. Antibody-dependent enhancement of coronavirus. Int J Infect Dis, 100:483-489.

[130]WuF, ZhaoS, YuB, et al., 2020. A new coronavirus associated with human respiratory disease in China. Nature, 579(7798):265-269.

[131]WuQ, WuW, ChenFF, et al., 2022. Highly sensitive and selective surface plasmon resonance biosensor for the detection of SARS-CoV-2 spike S1 protein. Analyst, 147(12):2809-2818.

[132]XuZ, ShiL, WangYJ, et al., 2020. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 8(4):420-422.

[133]YadavS, SadiqueMA, RanjanP, et al., 2021. SERS based lateral flow immunoassay for point-of-care detection of SARS-CoV-2 in clinical samples. ACS Appl Bio Mater, 4(4):2974-2995.

[134]YanC, CuiJ, HuangL, et al., 2020. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay. Clin Microbiol Infect, 26(6):773-779.

[135]YanSJ, AhmadKZ, WardenAR, et al., 2021. One-pot pre-coated interface proximity extension assay for ultrasensitive co-detection of anti-SARS-CoV-2 antibodies and viral RNA. Biosens Bioelectron, 193:113535.

[136]YangWJ, CaoQQ, QinL, et al., 2020. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. Journal of Infection, 80(4):388-393.

[137]YuanSJ, PanY, XiaY, et al., 2021. Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(4):318-329.

[138]YüceM, FiliztekinE, ÖzkayaKG, 2021. COVID-19 diagnosis—a review of current methods. Biosens Bioelectron, 172:112752.

[139]YueC, SongWL, WangL, et al., 2023. ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5. Lancet Infect Dis, 23(3):278-280.

[140]YueL, XieTH, YangT, et al., 2022. A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine. J Med Virol, 94(1):35-38.

[141]ZavaTT, ZavaDT, 2021. Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays. Bioanalysis, 13(1):13-28.

[142]ZhangCY, ShiDM, LiXY, et al., 2022. Microfluidic electrochemical magnetoimmunosensor for ultrasensitive detection of interleukin-6 based on hybrid of AuNPs and graphene. Talanta, 240:123173.

[143]ZhangYM, ZhangY, XieKB, 2020. Evaluation of CRISPR/Cas12a-based DNA detection for fast pathogen diagnosis and GMO test in rice. Mol Breed, 40:11.

[144]ZhuN, ZhangDY, WangWL, et al., 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 382(8):727-733.

Open peer comments: Debate/Discuss/Question/Opinion


Please provide your name, email address and a comment

Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE